In a response to a looming U.S. ban, Apple Inc. (NASDAQ:AAPL) has decided to release a variant of its latest watches without the blood oxygen feature, ensuring that sales in the country’s market remain unaffected. What Happened: Apple has taken out the blood oxygen feature from Apple Watch Series 9 and Apple Watch Ultra 2 models for sale in the U.S., reported CNBC on Wednesday. The decision comes in the wake of an intellectual property dispute with Masimo Corporation (NASDAQ:MASI), a medical device company, which led to a temporary halt on sales of Apple’s watches in the U.S. in December 2023….
